MedTrace Logo

Study of the Safety and Effectiveness of BC1036 Capsules to Treat Frequent Long-Term Cough

NCT01656668 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2013-08-02

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of BC1036 (theobromine) on cough-related quality of life and cough severity following 2 weeks' treatment.

Conditions

Interventions

DRUG

BC1036

Sponsors & Collaborators

  • Respicopea Limited

    lead INDUSTRY

Principal Investigators

  • Alyn Morice, BA(Hons) MB.B.Chir MA FRCP · Castle Hill Hospital

  • Fan Chung, MB, BS, MD, FRCP, DSc (PI) · Royal Brompton & Harefield NHS Foundation Trust

  • Warwick Coulson, BSc, MBBS, DipRCOG, MRCGP · Albany House Medical Centre

  • Alun George, MA MBBS, DRCOG, DCH, MRCGP · Staploe Medical Centre

  • Bernard Higgins, MB ChB, MRCP, MD · Freeman Health System

  • Alan Jackson, MB, BS · Sheepcot Medical Centre

  • Philip Marazzi, MB, BS · The Medical Centre

  • Ian Pavord, MB BS, MRCP, FRCP, DM · Glenfield Hospital

  • Surinder Birring, BSc,MBChB(Hons),MRCP,MD(PI) · King's College Hospital NHS Trust

  • Lorcan McGarvey, MBBCh,BAOHons,MRCP,MD,CCST(PI) · The Queen's University of Belfast

  • Richard Oliver, MB ChB, MRCGP · Ecclesfield Group Practice

  • Chris Strang, MB BS, D. Obst, RCOG M · Mortimer Surgery

  • Damien McNally, MB,BCh,BAO,DRCOG,DMH,MRCGP · Ormeau Road Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01656668 on ClinicalTrials.gov